Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tyler Sandow

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|June 14, 2023
Durable Outcomes Missing for Radiation Segmentectomy with Resin MicrospheresChristopher D Malone, Tyler Sandow
Ochsner Journal|July 9, 2021
Safety and Feasibility of Percutaneous Gastrostomy Placement in Patients on Antiplatelet TherapyRichard Tramel, Tyler Sandow, Daniel April, et al.
Journal of Vascular and Interventional Radiology : JVIR|September 11, 2024
The Sphere Conundrum: Author's Reply to Commentary on Voxel-Based Dosimetry with Glass MicrospheresTyler Sandow, Juan Gimenez, Kirk Fowers, et al.
Ochsner Journal|June 23, 2017
Clinical Images: Left Atrial Air Embolism Following Computed Tomography-Guided Lung BiopsyDaniel April, Tyler Sandow, Jacob Scheibal, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 25, 2016
Elevated Lung Shunt Fraction as a Prognostic Indicator for Disease Progression and Metastasis in Hepatocellular CarcinomaTyler Sandow, Daniel DeVun, Paul Gulotta, et al.
Ochsner Journal|April 2, 2015
Clinical Images - A Quarterly Column: Rare Neonatal Look at Chiari II Thoracic MyelomeningoceleTyler Sandow, James Milburn, Juanita Garces, et al.
Cancer Research Communications|July 29, 2024
Yttrium-90 Induces an Effector Memory Response with Neoantigen Clonotype Expansion: Implications for ImmunotherapyKelley Núñez, Tyler Sandow, Juan Gimenez, et al.
Hepatology Communications|April 20, 2026
Radioembolization (90Y) achieves higher response rates and reduces progression risk compared with DEB-TACE in hepatocellular carcinomaKelley Núñez, Navid Hasani, Julie Cronan, et al.
Cancers|April 12, 2022
Hypoalbuminemia Is a Hepatocellular Carcinoma Independent Risk Factor for Tumor Progression in Low-Risk Bridge to Transplant CandidatesKelley G Núñez, Tyler Sandow, Jai Patel, et al.
Clinical and Experimental Medicine|October 25, 2025
Sustained AFP-L3 or DCP expression is associated with progression risk and inferior outcomes in unresectable hepatocellular carcinomaKelley Núñez, Tyler Sandow, Jeff Burton, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Vascular and Interventional Radiology : JVIR|June 14, 2023
Durable Outcomes Missing for Radiation Segmentectomy with Resin MicrospheresChristopher D Malone, Tyler Sandow
Ochsner Journal|July 9, 2021
Safety and Feasibility of Percutaneous Gastrostomy Placement in Patients on Antiplatelet TherapyRichard Tramel, Tyler Sandow, Daniel April, et al.
Journal of Vascular and Interventional Radiology : JVIR|September 11, 2024
The Sphere Conundrum: Author's Reply to Commentary on Voxel-Based Dosimetry with Glass MicrospheresTyler Sandow, Juan Gimenez, Kirk Fowers, et al.
Ochsner Journal|June 23, 2017
Clinical Images: Left Atrial Air Embolism Following Computed Tomography-Guided Lung BiopsyDaniel April, Tyler Sandow, Jacob Scheibal, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 25, 2016
Elevated Lung Shunt Fraction as a Prognostic Indicator for Disease Progression and Metastasis in Hepatocellular CarcinomaTyler Sandow, Daniel DeVun, Paul Gulotta, et al.
Ochsner Journal|April 2, 2015
Clinical Images - A Quarterly Column: Rare Neonatal Look at Chiari II Thoracic MyelomeningoceleTyler Sandow, James Milburn, Juanita Garces, et al.
Cancer Research Communications|July 29, 2024
Yttrium-90 Induces an Effector Memory Response with Neoantigen Clonotype Expansion: Implications for ImmunotherapyKelley Núñez, Tyler Sandow, Juan Gimenez, et al.
Hepatology Communications|April 20, 2026
Radioembolization (90Y) achieves higher response rates and reduces progression risk compared with DEB-TACE in hepatocellular carcinomaKelley Núñez, Navid Hasani, Julie Cronan, et al.
Cancers|April 12, 2022
Hypoalbuminemia Is a Hepatocellular Carcinoma Independent Risk Factor for Tumor Progression in Low-Risk Bridge to Transplant CandidatesKelley G Núñez, Tyler Sandow, Jai Patel, et al.
Clinical and Experimental Medicine|October 25, 2025
Sustained AFP-L3 or DCP expression is associated with progression risk and inferior outcomes in unresectable hepatocellular carcinomaKelley Núñez, Tyler Sandow, Jeff Burton, et al.
Pageof 3